Influence of antiviral therapy in the long‐term outcome of recurrent hepatitis C virus infection following liver transplantation

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Transplant Infectious Disease

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tid.12097PMID 23725370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation

  2013cited by this paper
• Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

  2010cited by this paper
• Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

  2010cited by this paper
• Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

  2010cited by this paper
• Natural history of post–liver transplantation hepatitis C: A review of factors that may influence its course

  2009cited by this paper
• Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: Impact of donor age and baseline cirrhosis

  2009cited by this paper
• Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

  2008cited by this paper
• Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.

  2008cited by this paper
• The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age

  2008cited by this paper
• The natural history of recurrent hepatitis C and what influences this

  2008influential reference
• Infection in solid-organ transplant recipients.

  2007cited by this paper
• Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation

  2007cited by this paper
• Role of cell‐cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C

  2007cited by this paper
• Management of hepatitis C virus in the transplant patient.

  2007cited by this paper
• Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full‐Dose Peg‐Interferon and Ribavirin

  2006cited by this paper
• Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation

  2006cited by this paper
• Effect of Nonviral Factors on Hepatitis C Recurrence After Liver Transplantation

  2006cited by this paper
• Merging Models of Hepatitis C Virus Pathogenesis

  2005cited by this paper
• Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation

  2005cited by this paper
• Differential Effects of Donor Age in Liver Transplant Recipients Infected With Hepatitis B, Hepatitis C and Without Viral Hepatitis

  2005cited by this paper
• Comparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination Therapy

  2003influential reference
• Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C

  2003cited by this paper
• Liver Transplantation and Hepatitis C. Proceedings of a consensus development symposium.

  2003cited by this paper
• Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.

  2003cited by this paper
• Outcome and management of hepatitis C in liver transplant recipients.

  2003cited by this paper
• Definitions of cytomegalovirus infection and disease in transplant recipients.

  2002cited by this paper
• Contribution of donor age to the recent decrease in patient survival among HCV‐infected liver transplant recipients

  2002cited by this paper
• A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantation

  2002cited by this paper
• Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C

  2002cited by this paper
• The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.

  2002cited by this paper
• Adult-to-adult living donor liver transplantation

  2001cited by this paper
• A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients

  2001cited by this paper
• Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas.

  2001cited by this paper
• Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection

  2000cited by this paper
• Natural history of clinically compensated hepatitis C virus–related graft cirrhosis after liver transplantation

  2000cited by this paper
• THE INFLUENCE OF CYTOMEGALOVIRUS VIRAEMIA ON THE OUTCOME OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION12

  2000cited by this paper
• Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation

  2000cited by this paper
• Predictors of patient and graft survival following liver transplantation for hepatitis C

  1998cited by this paper
• Hepatitis C

  1998cited by this paper
• Clinical, virological, and histologic evolution of hepatitis C virus infection in liver transplant recipients.

  1998cited by this paper
• Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

  1997cited by this paper
• Banff schema for grading liver allograft rejection: An international consensus document

  1997cited by this paper
• Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

  1995cited by this paper
• Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database nomenclature and grading system for cellular rejection of liver allografts.

  1995cited by this paper
• Classification of chronic viral hepatitis: a need for reassessment.

  1991cited by this paper

• Outcomes of liver transplantation with donors older than 80 years in HCV patients treated with direct-action antivirals vs. non-HCV patients.

  2024cites this paper
• Expanding donor age in liver transplantation using liver grafts from nonagenarian donors

  2022cites this paper
• "Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals. Retrospective cohort study".

  2021cites this paper
• Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)‐Viremic Donors Into HCV‐Negative Recipients: Outcomes Following Liver Transplant of HCV‐Viremic Donors

  2019cites this paper
• Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over

  2018cites this paper
• The Impact of New Technologic and Molecular Advances in the Daily Practice of Gastrointestinal and Hepatobiliary Pathology.

  2017cites this paper
• Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation

  2017cites this paper
• Slower Fibrosis Progression Among Liver Transplant Recipients With Sustained Virological Response After Hepatitis C Treatment

  2015cites this paper
• Impact of fibrosis progression on clinical outcome in patients treated for post‐ transplant hepatitis C recurrence

  2015cites this paper
• Challenges of recurrent hepatitis C in the liver transplant patient.

  2014cites this paper
• Liver transplantation: fifty years of experience.

  2014cites this paper